arrow
E

E. Anders Kolb

Alfred I duPont Hospital for Children and Nemours Center for Cancer and Blood Disorders
H指数:59
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert Panel

儿童急性髓系白血病(AML)的诊断与管理:国际专家小组的共识建议

Blood
IF23.1
2025-10-220
PRE
Epigenomic diagnosis and prognosis of Acute Myeloid Leukemia

急性髓系白血病的表观基因组学诊断与预后

2025-07-290
OAAI
Treatment Intensification Does Not Improve Outcome for Children with Myeloid Leukemia of Down Syndrome

治疗强化并未改善唐氏综合征伴髓系白血病患儿的预后

BLOOD
IF23.1
2024-11-050
PRE
Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trials
2024-08-010
OAAI
CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children's Oncology Group
2024-02-013
OAAI
Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome
2023-10-278
OAAI
Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration

亚二倍体对小儿急性髓性白血病的生存有不利影响: i-bfm研究组合作

2023-03-202
OAAI
Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia
2023-02-2330
OAAI
Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation
2023-01-012
OAAI
Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia
2022-09-1921
OAAI
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy
2022-09-0122
OAAI